Related Posts
Guys , whoever is interviewing and planning to join , do ask project availablity on priority basis before you take decision. On Java front looks like there is some project issue due to recent slowdown in market. My offer was not revised even after agreement with recruiter because of this.
Publicis Sapient Publicis Groupe Publicis Media
I was in the final stages of an interview with Microsoft two weeks ago, in partner marketing. Then the recruiter told me they were putting the hiring process on hold to assess the need for the role. Well, then we heard about Microsoft layoffs last week. Seems like most were in Xbox and Project Alpha but there’s not a lot of information out there. Should I hold out any hope that I’m going to get this job? Any insights on how much these layoffs have impacted the marketing org and/or new hiring?
Hey, Fishies! We’re launching our first Interview/Q+A series "Portfolio Rewind: Would You Hire You?"
Like a portfolio review in reverse, creative leaders will share work they created when they first started out and critique it as if were a book that had just landed in their inbox. Then, tell us if they’d hire their younger selves knowing, and expecting, what they do now.
Drop in for get the chance to ask questions, and get your book reviewed by our guest. Hope you can make it!
zoom.us/j/92635977143
More Posts
What’s your spookiest recruiter ghost story?
Newbie to investing and never invested in a company that went through a reverse stock split.
In theory, I understand the market value should increase but I’m not seeing this reflected in the price and naturally my book value/ share is very disappointing.
A) When should I anticipate the stock appreciation to occur?
B) What’s the next move for companies that do this? Issue more shares?
TIA!
https://finance.yahoo.com/news/retransmission-hive-blockchain-announces-5-100000300.html
Additional Posts in Jobs in STEM
New to Fishbowl?
unlock all discussions on Fishbowl.




Chief
Networking within local biotech associations, research institutions, and conferences can help significantly. Sometimes certifications in clinical research or regulatory affairs also strengthen visibility.